Announcements Trials

Browse Landscape

Sponsor

Conditions

Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Myocarditis 1 Multiple Pulmonary Nodules 1 Liver Metastases 1 Hematologic Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoma, Lobular 1 Breast Neoplasms 1

Interventions

Bevacizumab 39 atezolizumab 26 durvalumab 24 Nivolumab 21 lenvatinib 20 tremelimumab 16 Specimen Handling 16 Magnetic Resonance Spectroscopy 13 sintilimab 11 pembrolizumab 11 Ipilimumab 10 tislelizumab 7 X-Rays 7 Sorafenib 7 Immunoglobulin G 7 regorafenib 6 Disulfides 6 Cyclophosphamide 6 cabozantinib 5 Radiotherapy 5 Radiosurgery 5 Blood Specimen Collection 5 Radiation 4 Oxaliplatin 4 Immunotherapy 4 Fluorouracil 4 Ethiodized Oil 4 Biopsy 4 fludarabine 3 donafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Positron Emission Tomography Computed Tomography × 90 days × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡